Cumulative Antibiotic Exposures Over Time and the Risk of Clostridium difficile Infection

作者: V. Stevens , G. Dumyati , L. S. Fine , S. G. Fisher , E. van Wijngaarden

DOI: 10.1093/CID/CIR301

关键词:

摘要: Background Clostridium difficile infection (CDI) is a major cause of hospital-acquired diarrhea and most commonly associated with changes in normal intestinal flora caused by administration antibiotics. Few studies have examined the risk CDI total dose, duration, or number antibiotics while taking into account complex exposures over time. Methods A retrospective cohort study conducted from 1 January to 31 December 2005 among hospitalized patients 18 years older receiving 2 more days Results The identified 10,154 hospitalizations for 7,792 unique 241 cases CDI, defined as detection C. toxin diarrheal stool sample within 60 discharge. We observed dose-dependent increases increasing cumulative antibiotics, antibiotic exposure. Compared who received only antibiotic, adjusted hazard ratios (HRs) those 2, 3 4, 5 were 2.5 (95% confidence interval [CI] 1.6-4.0), 3.3 (CI 2.2-5.2), 9.6 6.1-15.1), respectively. receipt fluoroquinolones was an increased metronidazole reduced risk. Conclusions Cumulative appear be CDI. Antimicrobial stewardship programs that focus on overall reduction dose well exposure substitution high-risk classes lower-risk alternatives may reduce incidence

参考文章(33)
L. V. McFarland, J. E. Clarridge, H. W. Beneda, G. J. Raugi, Fluoroquinolone Use and Risk Factors for Clostridium difficile-Associated Disease within a Veterans Administration Health Care System Clinical Infectious Diseases. ,vol. 45, pp. 1141- 1151 ,(2007) , 10.1086/522187
J. Pepin, N. Saheb, M.-A. Coulombe, M.-E. Alary, M.-P. Corriveau, S. Authier, M. Leblanc, G. Rivard, M. Bettez, V. Primeau, M. Nguyen, C.-E. Jacob, L. Lanthier, Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile–Associated Diarrhea: A Cohort Study during an Epidemic in Quebec Clinical Infectious Diseases. ,vol. 41, pp. 1254- 1260 ,(2005) , 10.1086/496986
Thomas M. Hooton, Suzanne F. Bradley, Diana D. Cardenas, Richard Colgan, Suzanne E. Geerlings, James C. Rice, Sanjay Saint, Anthony J. Schaeffer, Paul A. Tambayh, Peter Tenke, Lindsay E. Nicolle, Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America Clinical Infectious Diseases. ,vol. 50, pp. 625- 663 ,(2010) , 10.1086/650482
R. E. Polk, C. Fox, A. Mahoney, J. Letcavage, C. MacDougall, Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clinical Infectious Diseases. ,vol. 44, pp. 664- 670 ,(2007) , 10.1086/511640
Ursula Changela, Joan P. Cannon, Chinyere Aneziokoro, Palak S. Shah, Lizy Thottapurathu, Joseph Lentino, Risk factors and mortality associated with Clostridium difficile-associated diarrhoea at a VA hospital. International Journal of Antimicrobial Agents. ,vol. 24, pp. 562- 566 ,(2004) , 10.1016/J.IJANTIMICAG.2004.07.011
Heidi T. Chang, Dorota Krezolek, Stuart Johnson, Jorge P. Parada, Charlesnika T. Evans, Dale N. Gerding, Onset of symptoms and time to diagnosis of Clostridium difficile-associated disease following discharge from an acute care hospital. Infection Control and Hospital Epidemiology. ,vol. 28, pp. 926- 931 ,(2007) , 10.1086/519178
Louis Valiquette, Benoit Cossette, Marie-Pierre Garant, Hassan Diab, Jacques Pépin, Impact of a Reduction in the Use of High-Risk Antibiotics on the Course of an Epidemic of Clostridium difficile-Associated Disease Caused by the Hypervirulent NAP1/027 Strain Clinical Infectious Diseases. ,vol. 45, ,(2007) , 10.1086/519258
Joseph S. Solomkin, John E. Mazuski, John S. Bradley, Keith A Rodvold, Ellie J.C. Goldstein, Ellen J. Baron, Patrick J. O'Neill, Anthony W. Chow, E. Patchen Dellinger, Soumitra R. Eachempati, Sherwood Gorbach, Mary Hilfiker, Addison K. May, Avery B. Nathens, Robert G. Sawyer, John G. Bartlett, Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America Clinical Infectious Diseases. ,vol. 50, pp. 133- 164 ,(2010) , 10.1086/649554
R‐P Vonberg, Ed J Kuijper, Mark H Wilcox, F Barbut, P Tüll, P Gastmeier, European C. difficile‐Infection Control Group and the European Centre for Disease Prevention and Control (ECDC), PJ Van Den Broek, A Colville, B Coignard, T Daha, S Debast, BI Duerden, S Van Den Hof, T Van Der Kooi, HJH Maarleveld, E Nagy, DW Notermans, J O’Driscoll, B Patel, S Stone, C Wiuff, Infection control measures to limit the spread of Clostridium difficile Clinical Microbiology and Infection. ,vol. 14, pp. 2- 20 ,(2008) , 10.1111/J.1469-0691.2008.01992.X
Simon D. Baines, Jane Freeman, Mark H. Wilcox, Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model Journal of Antimicrobial Chemotherapy. ,vol. 55, pp. 974- 982 ,(2005) , 10.1093/JAC/DKI120